Benefit-risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia
- PMID: 10603070
- DOI: 10.1007/pl00014165
Benefit-risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
